Cannabis and Psychosis: What Degree of Proof Do We Require?

作者: Robin M. Murray , Marta Di Forti

DOI: 10.1016/J.BIOPSYCH.2016.02.005

关键词: CannabisPsychosisMedicinePsychiatryDegree (temperature)Marijuana AbuseBiological psychiatry

摘要: … Although THC is a partial agonist at the cannabinoid type 1 … and The Netherlands where high-potency cannabis has taken … wait for absolute proof that cannabis is a component cause of …

参考文章(9)
Suzanne H. Gage, Matthew Hickman, Stanley Zammit, Association Between Cannabis and Psychosis: Epidemiologic Evidence Biological Psychiatry. ,vol. 79, pp. 549- 556 ,(2016) , 10.1016/J.BIOPSYCH.2015.08.001
Pedro Gurillo, Sameer Jauhar, Robin M Murray, James H MacCabe, Does tobacco use cause psychosis? Systematic review and meta-analysis The Lancet Psychiatry. ,vol. 2, pp. 718- 725 ,(2015) , 10.1016/S2215-0366(15)00152-2
Amir Englund, Paul D Morrison, Judith Nottage, Dominic Hague, Fergus Kane, Stefania Bonaccorso, James M Stone, Avi Reichenberg, Rudolf Brenneisen, David Holt, Amanda Feilding, Lucy Walker, Robin M Murray, Shitij Kapur, Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Journal of Psychopharmacology. ,vol. 27, pp. 19- 27 ,(2013) , 10.1177/0269881112460109
Marco Colizzi, Conrad Iyegbe, John Powell, Gianluca Ursini, Annamaria Porcelli, Aurora Bonvino, Paolo Taurisano, Raffaella Romano, Rita Masellis, Giuseppe Blasi, Craig Morgan, Katherine Aitchison, Valeria Mondelli, Sonija Luzi, Anna Kolliakou, Anthony David, Robin M. Murray, Alessandro Bertolino, Marta Di Forti, Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis Schizophrenia Bulletin. ,vol. 41, pp. 1171- 1182 ,(2015) , 10.1093/SCHBUL/SBV032
M. Di Forti, H. Sallis, F. Allegri, A. Trotta, L. Ferraro, S. A. Stilo, A. Marconi, C. La Cascia, T. Reis Marques, C. Pariante, P. Dazzan, V. Mondelli, A. Paparelli, A. Kolliakou, D. Prata, F. Gaughran, A. S. David, C. Morgan, D. Stahl, M. Khondoker, J. H. MacCabe, R. M. Murray, Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users. Schizophrenia Bulletin. ,vol. 40, pp. 1509- 1517 ,(2014) , 10.1093/SCHBUL/SBT181
Marta Di Forti, Arianna Marconi, Elena Carra, Sara Fraietta, Antonella Trotta, Matteo Bonomo, Francesca Bianconi, Poonam Gardner-Sood, Jennifer O'Connor, Manuela Russo, Simona A Stilo, Tiago Reis Marques, Valeria Mondelli, Paola Dazzan, Carmine Pariante, Anthony S David, Fiona Gaughran, Zerrin Atakan, Conrad Iyegbe, John Powell, Craig Morgan, Michael Lynskey, Robin M Murray, Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet Psychiatry. ,vol. 2, pp. 233- 238 ,(2015) , 10.1016/S2215-0366(14)00117-5
Robin M. Murray, Mitul Mehta, Marta Di Forti, Different Dopaminergic Abnormalities Underlie Cannabis Dependence and Cannabis-Induced Psychosis Biological Psychiatry. ,vol. 75, pp. 430- 431 ,(2014) , 10.1016/J.BIOPSYCH.2014.01.011
Tabea Schoeler, Anna Monk, Musa B Sami, Ewa Klamerus, Enrico Foglia, Ruth Brown, Giulia Camuri, A Carlo Altamura, Robin Murray, Sagnik Bhattacharyya, Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. The Lancet Psychiatry. ,vol. 3, pp. 215- 225 ,(2016) , 10.1016/S2215-0366(15)00363-6
C J A Morgan, T P Freeman, J Powell, H V Curran, AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers Translational Psychiatry. ,vol. 6, pp. 1- ,(2016) , 10.1038/TP.2015.219